GURU
Global X Guru Index ETF · PSE
- Category Equity
- Expense Ratio 0.75%
- Listing Date Jun 05, 2012
- Volume 360.0
- Market Cap (AUM) $46.88M
Performance
-1.62%
1W
+3.41%
1M
+12.24%
3M
+17.6%
6M
+26.21%
YTD
+38.91%
1Y
Top Holdings
-
Name
Symbol%Assets
- NVIDIA CorporationNVDA2.35%
- Texas Pacific Land CorporationTPL2.06%
- Oracle CorporationORCL1.94%
- Apple Inc.AAPL1.85%
- United Therapeutics CorporationUTHR1.84%
- Planet Fitness, Inc. Class APLNT1.82%
- Guidewire Software, Inc.GWRE1.82%
- Expedia Group, Inc.EXPE1.80%
- Chipotle Mexican Grill, Inc.CMG1.79%
- Roblox Corp. Class ARBLX1.79%
Technical Analysis of GURU 2024-11-18
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2022-10-11 01:15
Ex-Bridgewater Executive Rolls Out Hedge Fund ETF(Yahoo Finance)
- 2022-09-20 03:00
Proposed ETFs Aim to Mimic Congress Stock Picks(Yahoo Finance)
- 2022-04-04 19:00
- 2022-03-23 19:00
- 2020-08-26 16:00
Yes, Transparency Is Still A Good Thing(Yahoo Finance)
- 2019-08-27 22:59
3 Ways to Follow the Smart Money(Investopedia)
- 2019-06-06 05:00
- 2019-04-09 00:30
5 Amazing ETF Strategies for Q2(Yahoo Finance)
- 2019-01-09 00:00
- 2019-01-08 19:00
Hedge Funds Top Markets in 2018: ETFs in Focus(Yahoo Finance)
- 2019-01-06 21:05
Winning ETF Strategies for 2019(Yahoo Finance)
- 2018-05-30 21:44
7 Stocks the Great Investors Have Bet Big On(Yahoo Finance)
- 2017-11-13 04:46
- 2017-07-06 22:09
How to Build a Winning ETF Portfolio for Second-Half 2017(Yahoo Finance)
- 2017-06-01 22:05
Guru ETF (GURU) Hits New 52-Week High(Yahoo Finance)
- 2017-05-29 21:30
- 2017-05-25 22:47
Beat the Market with These Guru ETFs(Yahoo Finance)
- 2017-05-08 20:18
Hedge Fund ETFs For A Lower Fee Than Actual Hedge Funds(Yahoo Finance)
- 2017-04-05 22:57
5 Unbeatable ETF Strategies for Q2(Yahoo Finance)
- 2017-03-23 19:35
Valeant Pharmaceuticals is Developing its Sales Force(Marketrealist)
- 2017-03-22 19:36
Valeants Dermatology Business Felt Pricing Pressure in 2016(Marketrealist)
- 2017-03-21 21:06
Xifaxan Expected to Witness Robust Growth in 2017(Marketrealist)
- 2017-03-20 22:37
Valeants Net Profit Margins Expected to Narrow in 2017(Marketrealist)
- 2017-02-16 22:52
Follow Warren Buffet With These ETF Strategies(Yahoo Finance)
- 2017-02-16 22:52
Follow Warren Buffett With These ETF Strategies(Yahoo Finance)
- 2017-01-25 20:30
How to Beat Hedge Funds with ETFs(Yahoo Finance)
- 2016-12-27 05:05
- 2016-12-23 00:10
Be Part of Buffett's Success Story with These 5 ETFs(Yahoo Finance)
- 2016-12-19 00:05
Factors behind Horizon Pharmas Volatility in December(Marketrealist)
- 2016-11-03 03:04
What Might Have Fueled Valeants Interest in Salix?(Marketrealist)
- 2016-11-02 20:00
New Goldman ETF tracks popular hedge fund stock bets(Yahoo Finance)
- 2016-10-20 23:02
As hedge funds suffer, so do their imitators(Marketwatch)
- 2016-09-14 03:16
Hedge Fund ETFs Still Fighting Head Winds(Yahoo Finance)
- 2016-08-26 12:01
- 2016-07-12 20:36
Investors Grab The Cash(Forbes)
- 2016-06-30 00:16
Thursday links: nurturing untapped potential(Yahoo Finance)
- 2016-06-02 21:48
- 2016-05-19 00:01
Hedge Funds Love This 'Boring' Sector(Yahoo Finance)
- 2016-04-20 15:21
Hedge Fund ETFs Just As Bad As Hedge Funds(Yahoo Finance)
- 2016-04-05 14:05
Understanding Analyst Expectations for Horizon(Yahoo Finance)
Page 1 of 3
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.